De Novo Fragment Design for Drug Discovery and Chemical Biology

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-3773|54|50|15079-15083

ISSN： 1433-7851

Source： ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol.54, Iss.50, 2015-12, pp. : 15079-15083

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generative Recurrent Networks for De Novo Drug Design

By  

MOLECULAR INFORMATICS, Vol. 37, Iss. 1-2, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erratum: Generative Recurrent Networks for De Novo Drug Design.

By  

MOLECULAR INFORMATICS, Vol. 37, Iss. 1-2, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fragment‐Based De Novo Design Reveals a Small‐Molecule Inhibitor of Helicobacter Pylori HtrA

By  

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 54, Iss. 35, 2015-08 ,pp. : 10244-10248

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fragment‐Based De Novo Design Reveals a Small‐Molecule Inhibitor of Helicobacter Pylori HtrA

By  

ANGEWANDTE CHEMIE, Vol. 127, Iss. 35, 2015-08 ,pp. : 10382-10386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Scaffold-Hopping Potential of Fragment-Based De Novo Design: The Chances and Limits of Variation

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 12, Iss. 4, 2009-05 ,pp. : 383-396

Bentham Science Publishers

Access to resources Recommend Favorite